Flexion Therapeutics Inc
SEC CIK 1419600 · FLXN · last insider filing 2021-11-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Colella Samuel D | Director | filed 2014–2021 |
| Milinazzo Alan | Director | filed 2014–2021 |
| Merrifield C ANN | Director | filed 2014–2021 |
| Mahaffy Patrick J | Director | filed 2014–2021 |
| Canute Scott A | Director | filed 2015–2021 |
| Stejbach Mark | Director | filed 2016–2021 |
| Lukatch Heath | Director | filed 2014–2021 |
| Clayman Michael D. | Director · President and CEO | filed 2014–2021 |
| Koppikar Utpal | Director | filed 2021–2021 |
| Kwo Elizabeth | Director | filed 2020–2021 |
| Mahatme Sandesh | Director | filed 2014–2020 |
| Jaffe Ross A MD | Director | filed 2014–2016 |
| Robertson Rebecca B | Director | filed 2014–2016 |
| Link William J PHD | Director | filed 2014–2016 |
| Atwood Brian G | Director | filed 2014–2016 |
| Lubash Barbara N | Director | filed 2014–2016 |
| Milder Donald B | Director | filed 2014–2016 |
| Bolzon Bradley J PhD | Director | filed 2014–2016 |
| Warden Charles M | Director | filed 2014–2016 |
| Versant Side Fund III, L.P. | Director | filed 2014–2016 |
| Versant Venture Capital III, L.P. | Director | filed 2014–2016 |
| Versant Ventures III, LLC | Director | filed 2014–2016 |
| Versant Development Fund III, L.P. | Director | filed 2014–2016 |
| Tordjman Rafael | Director | filed 2014–2014 |
| Schwab Andrew J. | Director | filed 2014–2014 |
| Jones Elaine V | Director | filed 2014–2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Driscoll Frederick W | Chief Financial Officer | filed 2014–2021 |
| Wentworth Kerry | Chief Regulatory Officer | filed 2017–2021 |
| Levine Mark S. | SVP & General Counsel | filed 2017–2021 |
| Andrews William T. | Chief Medical Officer | filed 2021–2021 |
| Willwerth Christina | Chief Strategy Officer | filed 2019–2021 |
| Layman Melissa | Chief Commercial Officer | filed 2020–2021 |
| Muzikant Adam | Chief Business Officer | filed 2021–2021 |
| Arkowitz David | Chief Financial Officer | filed 2018–2021 |
| Kelley Scott | Chief Medical Officer | filed 2017–2021 |
| Bodick Neil | Chief Scientific Officer | filed 2014–2020 |
| Deniz Yamo | Chief Medical Officer | filed 2017–2017 |
| Fratamico Arthur | Chief Business Officer | filed 2014–2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.